These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8458418)

  • 1. Peptide aldehydes as inhibitors of HIV protease.
    Sarubbi E; Seneci PF; Angelastro MR; Peet NP; Denaro M; Islam K
    FEBS Lett; 1993 Mar; 319(3):253-6. PubMed ID: 8458418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease.
    Kempf DJ
    Methods Enzymol; 1994; 241():334-54. PubMed ID: 7854187
    [No Abstract]   [Full Text] [Related]  

  • 3. Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.
    Yedidi RS; Muhuhi JM; Liu Z; Bencze KZ; Koupparis K; O'Connor CE; Kovari IA; Spaller MR; Kovari LC
    Biochem Biophys Res Commun; 2013 Sep; 438(4):703-8. PubMed ID: 23921229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model peptides to study the effects of P2 and P3 substitutions in statine-containing HIV proteinase inhibitors.
    Hui KY; Hermann RB; Manetta JV; Gygi T; Angleton EL
    FEBS Lett; 1993 Aug; 327(3):355-60. PubMed ID: 8348964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of HIV-1 protease inhibitors. I. Incorporation of a reduced peptide, simple aminoalcohol, and statine analog at the scissile site of substrate sequences.
    Sakurai M; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y
    Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1369-77. PubMed ID: 8403085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase.
    Brinkworth RI; Fairlie DP
    Biochim Biophys Acta; 1995 Nov; 1253(1):5-8. PubMed ID: 7492599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic.
    Kiso Y
    Adv Exp Med Biol; 1995; 362():413-23. PubMed ID: 8540352
    [No Abstract]   [Full Text] [Related]  

  • 9. A modular approach to HIV-1 proteinase inhibitor design.
    Uhlíková T; Konvalinka J; Pichová I; Soucek M; Kräusslich HG; Vondrásek J
    Biochem Biophys Res Commun; 1996 May; 222(1):38-43. PubMed ID: 8630071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of HIV-1 protease by interface peptides.
    Schramm HJ; Billich A; Jaeger E; Rücknagel KP; Arnold G; Schramm W
    Biochem Biophys Res Commun; 1993 Jul; 194(2):595-600. PubMed ID: 8343146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold.
    Alterman M; Björsne M; Mühlman A; Classon B; Kvarnström I; Danielson H; Markgren PO; Nillroth U; Unge T; Hallberg A; Samuelsson B
    J Med Chem; 1998 Sep; 41(20):3782-92. PubMed ID: 9748353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V; Berti F; Benedetti F; Miertus S
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
    Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem.
    Dunn BM; Pennington MW; Frase DC; Nash K
    Biopolymers; 1999; 51(1):69-77. PubMed ID: 10380354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial amides for dimerization inhibitors of HIV-1 protease.
    Bowman MJ; Chmielewski J
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1395-8. PubMed ID: 15006369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands.
    Ghosh AK; Takayama J; Kassekert LA; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4903-4909. PubMed ID: 26096678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.
    Thaisrivongs S; Janakiraman MN; Chong KT; Tomich PK; Dolak LA; Turner SR; Strohbach JW; Lynn JC; Horng MM; Hinshaw RR; Watenpaugh KD
    J Med Chem; 1996 Jun; 39(12):2400-10. PubMed ID: 8691434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors.
    Karpoormath R; Sayed Y; Govender P; Govender T; Kruger HG; Soliman MES; Maguire GEM
    Bioorg Chem; 2012 Feb; 40(1):19-29. PubMed ID: 21982718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
    Ghosh AK; Kincaid JF; Walters DE; Chen Y; Chaudhuri NC; Thompson WJ; Culberson C; Fitzgerald PM; Lee HY; McKee SP; Munson PM; Duong TT; Darke PL; Zugay JA; Schleif WA; Axel MG; Lin J; Huff JR
    J Med Chem; 1996 Aug; 39(17):3278-90. PubMed ID: 8765511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.